Canada Pension Plan Investment Board
MRSN icon

Canada Pension Plan Investment Board’s Mersana Therapeutics MRSN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,196
Closed -$918K – 1420
2024
Q1 		$918K Buy
+8,196
New +$815K ﹤0.01% 1048

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Canada Pension Plan Investment Board's MRSN Position: Q2 2024 in Review

Canada Pension Plan Investment Board sold out of Mersana Therapeutics (MRSN) in Q2 2024, closing a stake of 8,196 shares — an estimated $918K sold.

Canada Pension Plan Investment Board first reported a position in MRSN in Q1 2024 and held it in 1 quarter. The position peaked at $918K in Q1 2024. 120 funds tracked by Wall St. Rank hold MRSN as of Q2 2024.

  • Canada Pension Plan Investment Board reported no remaining Mersana Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 8,196 Mersana Therapeutics shares in Q2 2024, an estimated $918K.
  • Canada Pension Plan Investment Board first reported a position in Mersana Therapeutics in Q1 2024 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Mersana Therapeutics position peaked at $918K in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q2 2024.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2024, filed 12 Aug 2024.